A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism

Annals of Internal Medicine

Volumn 135, Issue 5, 2001, Pages 322-327

  Middeldorp, S ^a   Meinardi, J R ^a   Koopman, M M W ^a   Van Pampus, E C M ^a   Hamulyak K ^a   Van der Meer, J ^a   Prins, M H ^a   Buller H R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM; UNIVERSITY HOSPITAL; VEIN THROMBOSIS;

EID: 0035806996     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-5-200109040-00008     Document Type: Article

References (20)

1. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis
2. Resistance to activated protein C as a basis for venous thrombosis
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. Activated protein C resistance caused by Arg506Gln mutation in factor Va
5. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V
6. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
7. World distribution of factor V Leiden
8. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
9. Resistance to activated protein C in an unselected population of patients with pulmonary embolism
10. Are we ready for factor V Leiden screening?
11. Factor V:Q506 mutation-resistance to activated protein C (APC): Clinical implications with respect to family screening
12. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis
13. Incidence of venous thromboembolism in families with inherited thrombophilia
14. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation
15. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism
16. Low rate of venous thromboembolism in asymptomatic relatives of probands with factor V Leiden mutation
17. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
18. A prospective study of the incidence of deep-vein thrombosis within a defined urban population
19. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
20. Factor V Leiden: Should we screen oral contraceptive users and pregnant women?